← All candidates
Three insider buys in the last year — $376.8K in all.
28 filings on record.
CVRXCVRx, Inc.
NasdaqGS · Healthcare · $79.92M
$3.00
+0.00% · Sep 15
Three insider buys in the last year — $376.8K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 3 buys● 11 sells◆ 3 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$79.92M
Float
15.6M
58% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
1.3
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Jain Mudit K.
Bought $297.6K on Feb 20 — 46,800 sh @ $6.36, held indirect, 4.8% of their stake.
0 of 1 position beat the S&P
CHIEF OPERATING OFFICER
Binkowski Brent
Bought $76.4K on Aug 13 — 26,223 sh @ $2.91, held direct, 46% of their stake.
No completed positions to measure
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
22 more transactions on Pro →Context
Wall St
$5.92 avg target
+97.2% vs today · 6 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 5 quarters beat
Q2 '26−$0.53 act−$0.01
Q1 '26−$0.50 act+$0.00
Q4 '25−$0.46 act−$0.02
Q3 '25−$0.49 act+$0.01
Coverage
CVRx (CVRX) Moves 11.6% Higher: Will This Strength Last?Zacks · 06-29CVRx Stock Up on Humana's Medicare Coverage for Barostim TherapyZacks · 05-18Analysts Have Made A Financial Statement On CVRx, Inc.'s (NASDAQ:CVRX) First-Quarter ReportSimply Wall St. · 05-15Down 31.7% in 4 Weeks, Here's Why You Should You Buy the Dip in CVRx (CVRX)Zacks · 05-13
The file stays open
28 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice